GDNF hyperalgesia is mediated by PLCγ, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4‐binding protein versican

Authors:

Abstract
The function of the isolectin B4 (IB4+)‐binding and GDNF‐dependent Ret (Ret+)‐expressing non‐peptidergic subpopulation of nociceptors remain poorly understood. We demonstrate that acute administration of GDNF sensitizes nociceptors and produces mechanical hyperalgesia in the rat. Intrathecal IB4–saporin, a selective toxin for IB4+/Ret+‐nociceptors, attenuates GDNF but not NGF hyperalgesia. Conversely, intrathecal antisense to Trk A attenuated NGF but not GDNF hyperalgesia. Intrathecal administration of antisense oligodeoxynucleotides targeting mRNA for versican, the molecule that renders the Ret‐expressing nociceptors IB4‐positive (+), also attenuated GDNF but not NGF hyperalgesia, as did ADAMTS‐4, a matrix metalloprotease known to degrade versican. Finally, inhibitors for all five signaling pathways known to be activated by GDNF at GFRα1/Ret: PLCγ, CDK5, PI3K, MAPK/ERK and Src family kinases, attenuated GDNF hyperalgesia. Our results demonstrate a role of the non‐peptidergic nociceptors in pain produced by the neurotrophin GDNF and suggest that the IB4‐binding protein versican functions in the expression of this phenotype.

This publication has 63 references indexed in Scilit: